Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Is childhood pneumonia an unrecognised presentation of asthma?

Is childhood pneumonia an unrecognised presentation of asthma? Original Research local open access spirometry service rather than buy a CONCLUSION Table 2: Reversibility testing spirometer. Only 11% of practices surveyed currently Spirometry is GPIAG Random Total have this service available. Thus, there will need to be a under-used in Members Group major expansion in open access services, which will have general n = 349 n = 582 n = 931 corresponding cost implications for secondary care practice and Routine use of bronchodilator 280 (80%) 484 (83%) 764 (82%) equipment and staffing levels. many GPs reversibility for:- would prefer Asthma 270 (96%) 471 (97%) 741 (97%) COPD 220 (79%) 376 (78%) 596 (78%) Our results indicate that steroid challenge tests are to use a Standard dose of bronchodilator 204 (73%) 449 (93%) 653 (85%) performed infrequently and for an inadequate time hospital open Routine use of oral steroid 152 (44%) 156 (27%) 308 (33%) period. It is known that patients who respond to access service reversibility for:- inhaled bronchodilators do not necessarily respond rather than Asthma 87 (57%) 109 (70%) 196 (64%) COPD 133 (88%) 123 (79%) 256 (83%) to inhaled steroids, and therefore many patients are buy a 6 Dose of prednisolone above 135 (89%) 138 (88%) http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png npj Primary Care Respiratory Medicine Springer Journals

Is childhood pneumonia an unrecognised presentation of asthma?

Loading next page...
 
/lp/springer-journals/is-childhood-pneumonia-an-unrecognised-presentation-of-asthma-ZAkT9gtmAD
Publisher
Springer Journals
Copyright
Copyright © 1997 by General Practice Airways Group (GPIAG)
Subject
Medicine & Public Health; Medicine/Public Health, general; Primary Care Medicine; Internal Medicine; Pneumology/Respiratory System; Thoracic Surgery
eISSN
1475-1534
DOI
10.1038/pcrj.1997.5
Publisher site
See Article on Publisher Site

Abstract

Original Research local open access spirometry service rather than buy a CONCLUSION Table 2: Reversibility testing spirometer. Only 11% of practices surveyed currently Spirometry is GPIAG Random Total have this service available. Thus, there will need to be a under-used in Members Group major expansion in open access services, which will have general n = 349 n = 582 n = 931 corresponding cost implications for secondary care practice and Routine use of bronchodilator 280 (80%) 484 (83%) 764 (82%) equipment and staffing levels. many GPs reversibility for:- would prefer Asthma 270 (96%) 471 (97%) 741 (97%) COPD 220 (79%) 376 (78%) 596 (78%) Our results indicate that steroid challenge tests are to use a Standard dose of bronchodilator 204 (73%) 449 (93%) 653 (85%) performed infrequently and for an inadequate time hospital open Routine use of oral steroid 152 (44%) 156 (27%) 308 (33%) period. It is known that patients who respond to access service reversibility for:- inhaled bronchodilators do not necessarily respond rather than Asthma 87 (57%) 109 (70%) 196 (64%) COPD 133 (88%) 123 (79%) 256 (83%) to inhaled steroids, and therefore many patients are buy a 6 Dose of prednisolone above 135 (89%) 138 (88%)

Journal

npj Primary Care Respiratory MedicineSpringer Journals

Published: Jun 1, 1997

There are no references for this article.